[Blocking of adrenergic beta-receptors. A new therapeutic principle].
D000787:Angina Pectoris / Q000188:drug therapy; D001024:Aortic Valve Stenosis / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001808:Blood Vessels / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002319:Cardiovascular System; D004983:Ethanolamines / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D009130:Muscle, Smooth / Q000187:drug effects; D009449:Neurocirculatory Asthenia / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy; D010673:Pheochromocytoma / Q000188:drug therapy; D011433:Propranolol / Q000627:therapeutic use; D013565:Sympatholytics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D004983:Ethanolamines; D013565:Sympatholytics; D011433:Propranolol
Die Blockade der adrenergen Beta-Rezeptoren. Ein neues therapeutisches Prinzip.